2935. Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18
M Kim 1, J L Lee 2, S J Shin 3, W K Bae 4, H J Lee 5, J H Byun 6, Y J Choi 7, J Youk 1, C Y Ock 8, S Kim 8, H Song 8, K H Park 7, B Keam 9
2931. Editorial Comment: Prognostic Implications of CT-Defined Extranodal Extension of Metastatic Lymph Nodes in Patients with Non-Small Cell Lung Cancer.
2930. Conventional Versus Artificial Intelligence-Assisted Interpretation of Chest Radiographs in Patients With Acute Respiratory Symptoms in Emergency Department: A Pragmatic Randomized Clinical Trial.
Hwang EJ, Goo JM, Nam JG, Park CM, Hong KJ, Kim KH
2927. Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue
Soon-Chan Kim 1 2 3, Young-Eun Cho 1 2, Young-Kyoung Shin 1 2 3, Hyeon Jong Yu 4, Tamrin Chowdhury 4, Sojin Kim 4, Kyung Sik Yi 5, Chi-Hoon Choi 5 6, Sang-Hoon Cha 7 8, Chul-Kee Park 9, Ja-Lok Ku 10 11 12 13
2926. The Impact of 131I-Metaiodobenzylguanidine as a Conditioning Regimen of Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma.
Park HJ, Choi JY, Kim BK, Hong KT, Kim HY, Kim IH, Cheon GJ, Cheon JE, Park SH, Kang HJ.